AmirAli Talasaz, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 241,078 shares at $50.91 ($11.9M) on 2025-05-01, disclosed to the SEC on 2025-05-05.
Scheduled sale ($11.9M) by Co-Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.67 | 18,069 | $861K | 7.3% |
| 2 | $47.67 | 18,069 | $861K | 7.3% |
| 3 | $48.71 | 38,477 | $1.9M | 15.8% |
| 4 | $48.71 | 38,477 | $1.9M | 15.8% |
| 5 | $49.53 | 44,691 | $2.2M | 18.7% |
| 6 | $49.53 | 44,691 |
| $2.2M |
| 18.7% |
| 7 | $50.91 | 3,445 | $175K | 1.5% |
| 8 | $50.91 | 3,445 | $175K | 1.5% |
| 9 | $51.56 | 1,748 | $90K | 0.8% |
| 10 | $51.56 | 1,748 | $90K | 0.8% |
| 11 | $52.57 | 354 | $19K | 0.2% |
| 12 | $50.47 | 13,932 | $703K | 5.9% |
| 13 | $50.47 | 13,932 | $703K | 5.9% |
| Total | $49.17 avg | 241,078 | $11.9M | 100% |
| Filing → |
| GH | SELL | 2026-05-22 | $23.1M | — | Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |